Prospects for the Immunological Management of Lethal Tumors
- 1 January 1983
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 1 (5) , 409-421
- https://doi.org/10.3109/07357908309048509
Abstract
(1983). Prospects for the Immunological Management of Lethal Tumors. Cancer Investigation: Vol. 1, No. 5, pp. 409-421. doi: 10.3109/07357908309048509Keywords
This publication has 41 references indexed in Scilit:
- Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.The Journal of Experimental Medicine, 1982
- Treatment of B-Cell Lymphoma with Monoclonal Anti-Idiotype AntibodyNew England Journal of Medicine, 1982
- T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases.The Journal of Experimental Medicine, 1981
- Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphomaProceedings of the National Academy of Sciences, 1980
- T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.The Journal of Experimental Medicine, 1980
- Prevention of oncornavirus-induced sarcomas in cats by treatment with antiviral antibodiesNature, 1977
- ANTIGENIC PROPERTIES OF MURINE SARCOMA VIRUS-TRANSFORMED BALB/3T3 NONPRODUCER CELLSThe Journal of Experimental Medicine, 1972
- Decrease in tumor‐producing capacity of mouse cell lines following infection with mouse leukemia virusesInternational Journal of Cancer, 1971
- Prevention of AKR Leukemia by Thymectomy at Varying AgesActa Haematologica, 1967
- Tumour-specific immunity against spontneous rat tumoursInternational Journal of Cancer, 1966